<DOC>
	<DOCNO>NCT02008929</DOCNO>
	<brief_summary>To see safety efficacy inject MG4101 secondary treatment curative liver resection patient advance HCC high risk recurrence .</brief_summary>
	<brief_title>Evaluate Efficacy Safety MG4101 ( Ex Vivo Expanded Allogeneic NK Cell )</brief_title>
	<detailed_description>To see safety efficacy inject MG4101 ( Ex vivo expand allogeneic NK cell ) secondary treatment curative liver resection patient advance HCC high risk recurrence .</detailed_description>
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma , Hepatocellular</mesh_term>
	<criteria>1 . Under age 20 69 year age 2 . Childpugh class A 3 . After curative liver resection , diagnose hepatocellular carcinoma 4 . Modified UICC staging : stage 3 5. woman childbearing age , agree maintain adequate contraception measure clinical trial period . 6 . Agreed participate clinical trial , agree subject person legal representative agree write 1 . Less 20 year old , 70 year old old 2 . Metastasis hepatocellular carcinoma external party surgery 3. Rupture hepatocellular carcinoma ( HCC ) 4 . Hepatocellular carcinoma treat radiofrequency surgery therapeutic ( Radiofrequency ablation , RFA ) , carotid artery chemical embolization ( Transarterial chemoembolization , TACE ) , underwent radiation therapy , topical therapeutic 5. suspect serious infection 6. Who severe cardiovascular disease ( coronary artery disease require treatment , heart failure , arrhythmia , myocardial infarction , etc . ) 7 . Pregnant , plan pregnancy breastfeed woman 8 . Autoimmune Disease 9 . Those Latest within four week administration systemic steroid ( However , inhalation , intranasal corticosteroid topical administration corticosteroid shorttime administration blood transfusion , reason exclude ) 10 . Latest within four week take immunosuppressive drug Cyclosporine A 11 . Within last 5 year diagnose liver cancer malignancy 12 . Investigator complete effectiveness safety pharmaceutical product clinical trial evaluation medical condition interfere character judge</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>69 Years</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>NKCELL</keyword>
</DOC>